Sept 13 (Reuters) - Fennec Pharmaceuticals Inc FENC.O
* Fennec announces preliminary results of SIOPEL 6 study on PEDMARK(sodium thiosulfate) to be presented at the 49th Congress of the International Society Of Pediatric Oncology (SIOP) 2017 meeting
* Says SIOPEL 6 shows that addition of sodium thiosulfate significantly reduces incidence of cisplatin-induced hearing loss
* Says combination of cis+sts was generally well tolerated
* Says randomised phase III trial shows addition of sodium thiosulfate significantly reduces incidence of cisplatin-induced hearing loss